DiscoverASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s ForumRetina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases
Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

Update: 2023-11-17
Share

Description

On this episode, Dr. Timothy Murray welcomes Dr. Baruch Kuppermann, Gavin Herbert Eye Institute, University of California, Irvine, California, to explore evidence from other specialties regarding cross-switching between biosimilars, and learn if there are any foreseen patient safety concerns for retina specialists.

For more information visit www.ASRS.org/JVRDForum.

Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care. 

Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.

Explore the podcast

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

American Society of Retina Specialists (ASRS)